Orr Inbar

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

Digital

Over 90% of experimental therapies that reach human trials fail to make it to market.

News

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.